Healthcare provider profile · identity verified

Michael L Sand, DO

Internal Medicine · MOORHEAD, MN · NPI 1154343705

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	797	195
Rosuvastatin Calcium	Rosuvastatin Calcium	627	202
Lisinopril	Lisinopril	619	162
Omeprazole	Omeprazole	576	142
Amlodipine Besylate	Amlodipine Besylate	542	142
Levothyroxine Sodium	Levothyroxine Sodium	510	116
Losartan Potassium	Losartan Potassium	439	113
Simvastatin	Simvastatin	414	103
Metoprolol Succinate	Metoprolol Succinate	395	99
Eliquis	Apixaban	351	65
Tamsulosin Hcl	Tamsulosin Hcl	327	99
Metformin Hcl	Metformin Hcl	324	82
Pantoprazole Sodium	Pantoprazole Sodium	282	52
Gabapentin	Gabapentin	269	68
Hydrochlorothiazide	Hydrochlorothiazide	260	72
Furosemide	Furosemide	249	61
Metoprolol Tartrate	Metoprolol Tartrate	235	64
Trazodone Hcl	Trazodone Hcl	209	48
Sertraline Hcl	Sertraline Hcl	207	47
Duloxetine Hcl	Duloxetine Hcl	202	42
Finasteride	Finasteride	182	51
Carvedilol	Carvedilol	171	40
Baclofen	Baclofen	158	25
Warfarin Sodium	Warfarin Sodium	154	50
Famotidine	Famotidine	148	35
Ozempic	Semaglutide	148	28
Fluticasone Propionate	Fluticasone Propionate	145	52
Escitalopram Oxalate	Escitalopram Oxalate	142	31
Donepezil Hcl	Donepezil Hcl	139	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	139	44
Potassium Chloride	Potassium Chloride	138	32
Bupropion Xl	Bupropion Hcl	128	24
Jardiance	Empagliflozin	127	29
Venlafaxine Hcl Er	Venlafaxine Hcl	117	23
Tramadol Hcl	Tramadol Hcl	112	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	33
Mirtazapine	Mirtazapine	108	28
Allopurinol	Allopurinol	102	30
Atenolol	Atenolol	102	21
Clopidogrel	Clopidogrel Bisulfate	101	27
Memantine Hcl	Memantine Hcl	99	18
Torsemide	Torsemide	99	18
Ropinirole Hcl	Ropinirole Hcl	94	13
Alendronate Sodium	Alendronate Sodium	93	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	87	22
Metformin Hcl Er	Metformin Hcl	87	22
Montelukast Sodium	Montelukast Sodium	80	16
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	79	79
Citalopram Hbr	Citalopram Hydrobromide	79	27
Spironolactone	Spironolactone	78	29
Pravastatin Sodium	Pravastatin Sodium	74	26
Levetiracetam	Levetiracetam	69	suppressed
Myrbetriq	Mirabegron	67	11
Glipizide Er	Glipizide	61	18
Prednisone	Prednisone	59	20
Fluoxetine Hcl	Fluoxetine Hcl	57	17
Divalproex Sodium	Divalproex Sodium	56	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	14
Diclofenac Sodium	Diclofenac Sodium	53	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	suppressed
Calcitriol	Calcitriol	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	27
Doxepin Hcl	Doxepin Hcl	47	11
Hydralazine Hcl	Hydralazine Hcl	47	12
Digoxin	Digoxin	44	suppressed
Xarelto	Rivaroxaban	44	11
Pregabalin	Pregabalin	42	suppressed
Glipizide	Glipizide	41	12
Bumetanide	Bumetanide	39	suppressed
Alprazolam	Alprazolam	37	15
Dutasteride	Dutasteride	37	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Novolog Flexpen	Insulin Aspart	34	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Lorazepam	Lorazepam	32	15
Isosorbide Dinitrate	Isosorbide Dinitrate	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Flecainide Acetate	Flecainide Acetate	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Dilantin	Phenytoin Sodium Extended	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	11
Lactulose	Lactulose	25	suppressed
Metolazone	Metolazone	25	suppressed
Nicotrol Ns	Nicotine	25	suppressed
Nitroglycerin	Nitroglycerin	25	16
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Olanzapine	Olanzapine	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Ketoconazole	Ketoconazole	22	15
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	21	21
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Enulose	Lactulose	20	suppressed
Estradiol	Estradiol	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Hydroxyurea	Hydroxyurea	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Amoxicillin	Amoxicillin	17	14
Hydrocortisone	Hydrocortisone	17	12
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Teriflunomide	Teriflunomide	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	13	suppressed
Formoterol Fumarate	Formoterol Fumarate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Anastrozole	Anastrozole	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Diazepam	Diazepam	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nystatin	Nystatin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Synthroid	Levothyroxine Sodium	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error